Details of Drug-Drug Interaction
| Drug General Information (ID: DDII7SELBN) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Phenylpropanolamine | Drug Info | Alimemazine | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Appetite Depressants | Antihistamines | |||||||
| Structure | |||||||||
| Mechanism of Phenylpropanolamine-Alimemazine Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antagonize the effect of dopaminergic agents Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Phenylpropanolamine | Alimemazine | |||||||
| Mechanism |
Dopaminergic effects Dopamine receptor Agonist |
Antidopaminergic effects Dopamine receptor Antagonist |
|||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Dopamine receptor | Structure Sequence | |||||||
| Protein Family | G-protein coupled receptor 1 family | ||||||||
| Protein Function |
Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
Click to Show/Hide
|
||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Amphetamine, amphetamine derivatives, and other CNS stimulants should generally not be used, particularly for weight reduction, in patients treated with phenothiazines. | ||||||||

